Qms Medical Allied Services Ltd (QMSMEDI) Financials - Quarterly Results, Profit & Loss, Balance Sheet, Cash Flow Qms Medical Allied Services Ltd reported sales of ₹56.87 Cr, operating profit of ₹8.31 Cr (OPM 14.61%) and net profit of ₹3.96 Cr for the quarter ended Jun 2026. Figures in ₹ crore, consolidated where available.
QMSMEDI quarterly results (₹ Cr) Metric Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026 Jun 2026 Sales 37.2 43.87 44.58 46.5 44.7 37.26 44.42 56.87 Expenses 29.96 36.93 38.21 39.96 37.78 30.51 38.5 48.56 Operating Profit 7.24 6.94 6.37 6.54 6.92 6.75 5.92 8.31 OPM 19.46% 15.82% 14.29% 14.06% 15.48% 18.12% 13.33% 14.61% Other Income 0.33 0.19 1.09 0.32 0.22 0.3 0.22 0.42 Interest 1.07 1.31 1.41 1.44 1.36 1.75 2.08 1.71 Depreciation 0.84 0.86 1.36 0.93 0.94 1.02 1.39 1.47 Profit before tax 5.66 4.96 4.69 4.49 4.84 4.28 2.67 5.55 Tax 25.27% 30.24% 23.24% 29.62% 26.24% 25.7% 29.21% 28.65% Net Profit 4.23 3.47 3.6 3.16 3.58 3.17 1.88 3.96 EPS in Rs 1.78 1.51 1.73 1.52 1.61 1.24 0.82 1.89
QMSMEDI profit & loss, annual (₹ Cr) Metric Mar 2024 Mar 2025 Mar 2026 TTM Sales 122 156 173 183 Expenses 104 130 146 155 Operating Profit 18 25 27 28 OPM 15% 16% 15% 15% Other Income 0 2 1 1 Interest 3 5 7 7 Depreciation 3 4 5 5 Profit before tax 12 19 16 17 Tax 26% 27% 28% - Net Profit 9 14 12 13 EPS in Rs 4.66 6.26 5.21 5.56 Dividend Payout 0% 0% 10% -
QMSMEDI balance sheet (₹ Cr) Metric Mar 2024 Mar 2025 Sep 2025 Mar 2026 Equity Capital 18 18 19 19 Reserves 61 72 86 85 Borrowings 35 60 58 68 Other Liabilities 22 40 47 41 Total Liabilities 135 190 210 213 Fixed Assets 24 53 55 57 CWIP 2 3 0 0 Investments 2 3 1 5 Other Assets 108 131 154 150 Total Assets 135 190 210 213
QMSMEDI cash flows (₹ Cr) Metric Mar 2024 Mar 2025 Mar 2026 Cash from Operating Activity 1 20 19 Cash from Investing Activity -3 -45 -20 Cash from Financing Activity 0 26 1 Net Cash Flow -1 1 0 Free Cash Flow 1 20 19 CFO/OP 26% 101% 91%
QMSMEDI ratios Metric Mar 2024 Mar 2025 Mar 2026 Debtor Days 124 101 142 Inventory Days 172 176 181 Days Payable 90 76 73 Cash Conversion Cycle 205 202 250 Working Capital Days 148 100 105 ROCE - 17% 13%